SAN FRANCISCO--(BUSINESS WIRE)--Voce Capital Management LLC (“Voce”), which is seeking to elect three independent directors to the Board of CONMED Corporation (“ConMed” or the “Company”) (Nasdaq:CNMD) at the Company’s delayed annual meeting on September 10, 2014, today poses a number of important questions to Curt Hartman, ConMed’s “interim” CEO:
In the coming days, Voce and its nominees, James W. Green, CEO of Analogic, and Joshua H. Levine, CEO of Accuray, will be meeting with many of ConMed’s largest investors. Voce is aware that ConMed and Mr. Hartman are doing the same, and so on behalf of shareholders Voce respectfully asks that Mr. Hartman answer the following questions, which are essential for shareholders to understand prior to casting their ballots:
Hey, check out all the research scientist jobs. Post your resume today!
